OTC, Supplement Co-Packaging Potential Could Be Clipped By FDA Proposed Rule

Innovus Pharmaceuticals is among the firms offering supplements and OTC drugs sold together, an option CRN trade group encourages FDA to allow. FDA will determine on a case-by-case basis whether already available co-packaged OTCs and supplements violate a proposed rule on drug co-packaging.

An FDA proposed rule that deems dietary supplements unapproved drugs when co-packaged with pharmaceutical products could put firms like Innovus Pharmaceuticals Inc. in an enforcement bullseye if made final in its current form.

Innovus in July launched tandem sales of its Apeaz OTC pain relief topical and its ArthriVarx joint health supplement, with...